{"id":"placebo-of-ad-2282","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL577163","moleculeType":"Small molecule","molecularWeight":"502.58"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, AD-2282 does not interact with any biological molecules or systems. It is used as a control in clinical trials to compare the efficacy of active treatments.","oneSentence":"This drug is a placebo, meaning it has no active therapeutic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:03.113Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06747936","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282","status":"NOT_YET_RECRUITING","sponsor":"Addpharma Inc.","startDate":"2025-02","conditions":"Primary Hypercholesterolemia","enrollment":110}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of AD-2282","genericName":"Placebo of AD-2282","companyName":"Addpharma Inc.","companyId":"addpharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}